Summary and Comparison of Atrial Septal Defect Closure Devices

Area of Science:

• Cardiology
• Medical Devices
• Interventional Procedures

Background:

• Numerous transvenous devices have been developed for nonsurgical closure of atrial septal defects (ASD).
• Currently, no ASD closure devices are approved for general clinical use, with many discontinued and others in clinical trials.
• No prospective, randomized clinical trials exist to directly compare the available devices.

Purpose of the Study:

• To review the current landscape of transvenous atrial septal defect closure devices.
• To assess the feasibility, safety, and effectiveness of investigational ASD closure devices.
• To identify key differentiating factors among devices for future clinical consideration.

Main Methods:

• Review of existing clinical trial data for various ASD closure devices.
• Comparative analysis of reported feasibility, safety, and effectiveness metrics.
• Evaluation of device-specific characteristics including delivery sheath size, implantation ease, cost, and availability.

Main Results:

• All investigated ASD closure devices demonstrate similar feasibility, safety, and effectiveness based on separate clinical trials.
• Significant variations exist among devices concerning delivery sheath size, ease of implantation, cost, and availability.
• No single device has emerged as superior across all evaluated parameters.

Conclusions:

• While current ASD closure devices show comparable performance, distinct practical considerations necessitate careful selection.
• Regulatory approval and long-term follow-up data from extensive clinical use are crucial for determining optimal device choice.
• Further research and comparative trials are needed to guide the selection of the most appropriate device for specific clinical scenarios.